English
Choose your country/region and language
Your experience may change as only information for the country or region you select will be presented.
Dr. Lindsay Sun, M.D., M.S.
Dr. Sun joined Beckman Coulter in 2009 and has focused on bringing clinical insights into product development for Immunoassay projects, currently working on biomarkers in heart failure, blood virus, and Reproductive Endocrinology. Her expertise in statistics and knowledge of medical needs ensure the quality of research study design and analysis.
Dr. Sun currently represents Beckman Coulter at the IFCC Committee on Clinical Applications of Cardiac Biomarkers and is an associate member of Early Detection Research Network (EDRN) under NIH for biomarker discovery and validation in early cancer detection.
Dr. Sun received her M.D. from a physician-scientist dual-degree program at Shanghai Medical University, China. She was an Endocrinologist in Shanghai and received her M.S. degree in Statistics from North Carolina State University.
Articles
The Impact of IL-6 on Severe COVID-19 Patients
Elevations in IL-6 levels may be an important mediator when severe systemic inflammatory responses occur in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Learn more about the connection between IL-6, Cytokine Storm Syndrome and COVID-19 in this blog.
The evolution of high-sensitivity HIV diagnostic testing
High-sensitivity diagnostic immunoassay testing is vital for meeting the increased HIV testing demands and enabling earlier treatment, which may curb viral transmissions by detecting infections sooner.
